$22+ Billion Worldwide Cardiac Monitoring & Cardiac Rhythm Management Industry to 2026 – Featuring Berlin Heart, Cardiac Science Corp and LivaNova Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Cardiac Monitoring & Cardiac Rhythm Management Market (2021-2026) by Product, Type, End-user, Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 22.64 Bn in 2021 and is expected to reach USD 28.62 Bn by 2026, growing at a CAGR of 4.8%.

The increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market. The implantable device technology uses complementary metal-oxide-semiconductor (CMOS) which are vulnerable to damage by the therapeutic doses of radiation, but it can vary according to the type of device in use. This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences. On the other hand, the high cost of these devices with limited insurance coverage is limiting the growth of the market.

Market Segmentation

By Product, the market is classified into ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices, Cardiac Output Monitoring Devices, Event Monitors and Smart ECG Monitors.

By Type, the market is classified into Defibrillators, Pacemakers and Others.

By End User, the market is classified amongst Hospitals, Clinics, Cardiac Centres, Ambulatory Surgery Centers, and Other End Users.

By Geography, North American region holds the largest share and is the dominating region in the cardiac monitoring and cardiac rhythm management devices market followed by Europe.

Recent Developments

1. In October 2020, Healthcare major Abbott confirmed its launch of next-generation heart rhythm management devices in India. The company introduced its new Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronisation Therapy Defibrillator (CRT-D) devices for people with abnormal heart rhythms and heart failure. The devices also offered new opportunities for patient engagement and remote monitoring through smartphone connectivity and connected applications.

2. In December 2020, CardioComm, a global provider of consumer heart monitoring and electrocardiogram (‘ECG’) device and software solutions, confirmed its technology integration agreement with LiveCare Corp. (‘LiveCare’) and a Value-Added Reseller and Distribution Agreement with Alliance Tele-Med (‘Alliance’), to provide integrated ECG monitoring through the LiveCare Link+ device and telemedicine platform.

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Cardiac Monitoring & Cardiac Rhythm Management Market.
• The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
• The report also contains the competitive analysis using Competitive Quadrant, the analyst’s proprietary competitive positioning tool.

Report Highlights:

• A complete analysis of the market, including parent industry
• Important market dynamics and trends
• Market segmentation
• Historical, current, and projected size of the market based on value and volume
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Market Dynamics

Drivers

• Rising prevalence of cardiovascular disease
• Availability of reimbursement for CM & CRM devices
• Launch of innovative products by market players
• Increasing investments, funds, and grants for research on CM & CRM devices
• Growing preference for wearable cardiac devices

Restraints

• Frequent product recalls

Opportunities

• Measures to reduce infections caused due to CIEDs

Challenges

• Risk of associated cyber security vulnerabilities
• Stringent regulatory requirements delaying the approval of cardiac devices
• Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices

Companies Mentioned

• Abbott Laboratories
• Abiomed, Inc.
• ACS Diagnostics
• Alivecor, Inc.
• Amiitalia
• Applied Cardiac System
• Asahi Kasei Corporation
• Berlin Heart GmbH
• Bexen Cardio
• BioTelemetry
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• BPL Medical Technologies
• BTL
• Cardiac Science Corporation
• Cardionet Inc.
• General Electric Company (GE)
• Hill-Rom Holdings, Inc.
• Jarvik Heart, Inc.
• Koninklijke Philips N.V.
• Lepu Medical Technology
• LivaNova PLC
• Medtronic plc
• MeTrax GmbH
• MicroPort Scientific Corporation
• Mortara Instrument, Inc.
• Narang Medical Limited
• Nihon Kohden Corporation
• OSI Systems, Inc.
• OSYPKA
• Philips Healthcare
• Progetti Srl
• ReliantHeart Inc.
• SCHILLER AG
• Shenzhen Mindray Bio-Medical Electronics
• Shree Pacetronix
• Siemens AG
• Spacelabs healthcare
• St. Jude Medical, Inc.
• Stryker Corporation
• Zoll Medical Corporation

For more information about this report visit https://www.researchandmarkets.com/r/c9nmau

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900